Clinical Trials Browser

Terminated × Leukemia, Myeloid, Acute × avelumab × Clear all

NCT02953561 2020-10-22

Avelumab and Azacitidine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia

Phase 1/2 Terminated

19 enrolled 11 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute